Related Experiment Videos
Respiratory effects of nefopam
Clinical Pharmacology and Therapeutics
|August 1, 1975
Summary
Nefopam, a new analgesic, did not depress respiration at therapeutic doses, unlike morphine. This study highlights nefopam
Area of Science:
- Pharmacology
- Respiratory Medicine
- Anesthesiology
Background:
- Opioid analgesics like morphine can cause significant respiratory depression.
- Novel analgesics are needed with improved safety profiles regarding respiratory function.
Purpose of the Study:
- To compare the respiratory effects of nefopam with morphine.
- To evaluate the respiratory safety of nefopam as a potent analgesic.
Main Methods:
- A comparative respiratory study design.
- Administration of therapeutic dosages of nefopam and morphine.
- Monitoring of respiratory parameters.
Main Results:
- Morphine demonstrated potent respiratory depressant effects at therapeutic dosage.
- Nefopam did not exhibit significant respiratory depression at therapeutic dosage.
Conclusions:
- Nefopam presents a potentially safer alternative to morphine regarding respiratory side effects.
- Nefopam's lack of respiratory depression warrants further investigation for pain management.